Cargando…
Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
Induction of HIV‐1 broadly neutralizing antibodies (bnAbs) to date has only been observed in the setting of HIV‐1 infection, and then only years after HIV transmission. Thus, the concept has emerged that one path to induction of bnAbs is to define the viral and immunologic events that occur during H...
Autores principales: | Bonsignori, Mattia, Liao, Hua‐Xin, Gao, Feng, Williams, Wilton B., Alam, S. Munir, Montefiori, David C., Haynes, Barton F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302796/ https://www.ncbi.nlm.nih.gov/pubmed/28133802 http://dx.doi.org/10.1111/imr.12509 |
Ejemplares similares
-
Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development
por: Wiehe, Kevin, et al.
Publicado: (2018) -
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023) -
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
por: Henderson, Rory, et al.
Publicado: (2019) -
Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
por: Hraber, Peter, et al.
Publicado: (2015) -
HIV mRNA Vaccines—Progress and Future Paths
por: Mu, Zekun, et al.
Publicado: (2021)